药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Cysteamine
Molindone
The risk or severity of adverse effects can be increased when Clomipramine is combined with Molindone.
Cysteamine
Nitrazepam
The risk or severity of adverse effects can be increased when Clomipramine is combined with Nitrazepam.
Cysteamine
Prazepam
The risk or severity of adverse effects can be increased when Clomipramine is combined with Prazepam.
Cysteamine
Fludiazepam
The risk or severity of adverse effects can be increased when Clomipramine is combined with Fludiazepam.
Cysteamine
Cathinone
The risk or severity of adverse effects can be increased when Clomipramine is combined with Cathinone.
Cysteamine
Ethyl loflazepate
The risk or severity of adverse effects can be increased when Clomipramine is combined with Ethyl loflazepate.
Cysteamine
Dimethyltryptamine
The risk or severity of adverse effects can be increased when Clomipramine is combined with Dimethyltryptamine.
Cysteamine
Fencamfamin
The risk or severity of adverse effects can be increased when Clomipramine is combined with Fencamfamin.
Cysteamine
Bufotenine
The risk or severity of adverse effects can be increased when Clomipramine is combined with Bufotenine.
Cysteamine
Chlormezanone
The risk or severity of adverse effects can be increased when Chlormezanone is combined with Clomipramine.
Cysteamine
Apalutamide
The serum concentration of Clomipramine can be increased when it is combined with Apalutamide.
Cysteamine
Lacidipine
Clomipramine may increase the hypotensive activities of Lacidipine.
Cysteamine
Vemurafenib
The serum concentration of Clomipramine can be increased when it is combined with Vemurafenib.
Cysteamine
Sodium phosphate, monobasic
The risk or severity of seizure can be increased when Clomipramine is combined with Sodium phosphate, monobasic.
Cysteamine
Osimertinib
The serum concentration of Clomipramine can be decreased when it is combined with Osimertinib.
Cysteamine
Ziconotide
The risk or severity of adverse effects can be increased when Clomipramine is combined with Ziconotide.
Cysteamine
Lofepramine
The risk or severity of adverse effects can be increased when Clomipramine is combined with Lofepramine.
Cysteamine
Melitracen
The risk or severity of adverse effects can be increased when Clomipramine is combined with Melitracen.
Cysteamine
Tiapride
The risk or severity of adverse effects can be increased when Clomipramine is combined with Tiapride.
Cysteamine
Tropisetron
The risk or severity of adverse effects can be increased when Clomipramine is combined with Tropisetron.